MindMap Gallery Regeneron Organizational Chart

Regeneron Organizational Chart

This organizational chart reveals the innovative structure behind Regeneron, a leader in biotechnology, highlighting its research-centric approach. Board of Directors: ensures governance and strategic direction (audit, compensation, compliance). CEO oversees critical functions: corporate strategy (M&A, partnerships), scientific leadership (CSO), commercial operations (marketing, sales), finance, legal, HR. Research & Discovery Core Center drives advancements through: Biological disciplines: immunology, oncology, ophthalmology, cardiovascular, metabolic, genetic diseases. Enabling technology platforms: VelociSuite (VelociGene, VelociMouse, VelociHum), antibody discovery (bispecifics, monoclonal), genetics (target identification), RNA (siRNA, ASO), gene therapy. Preclinical Development: pharmacology (efficacy, safety), toxicology, ADME, formulation, biomarker discovery. Clinical Development: clinical operations (Phase 1–3 trials), regulatory affairs (FDA, EMA), pharmacovigilance, medical affairs (scientific communication), biostatistics, data management. Manufacturing: process development (scale-up), quality assurance (cGMP), production (mammalian cell culture, purification), supply chain (logistics, distribution). Collaborations: Sanofi (DUPIXENT), Bayer (EYLEA), Alnylam (RNA), Intellia (CRISPR). This robust framework supports discovery and development, transforming scientific breakthroughs into life-changing therapies (EYLEA, DUPIXENT, LIBTAYO, REGEN-COV).

Edited at 2026-03-25 15:03:02
PlotWizard
PlotWizard

Regeneron Organizational Chart

PlotWizard
PlotWizard
  • Recommended to you
  • Outline